Outset Medical, Inc. OM
Set alert
4.02 USD -0.01 -0.25%
At close · Nov 2
4.02 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
3.98 Day range 4.40
2.84 52-week range 12.97
- YTD
- +8.36%
- 1 year
- -69.36%
- Open
- 4.18
- Prev close
- 4.03
- Mkt cap
- 75.56M
- Vol
- 54.26K
- Avg vol
- 152.01K
- EPS
- -4.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.98
- High
- 4.40
- Forward P/E
- -0.89
- Beta
- 1.95
- Short ratio
- 2.94
- Inst. own
- 52.16%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 0.82834
- 200-d avg
- 2.07
- 1y target
- 4.00
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 22 hours ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
Financial health
Altman Z-Score
-6.08 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.7×
FY 2018 5y median -1.6× FY 2025
P/S 0.5×
FY 2018 5y median 2.1× FY 2025
P/B 0.4×
FY 2018 5y median 2.2× FY 2025
P/FCF -1.2×
FY 2018 5y median -2.0× FY 2025
EV/EBITDA -2.0×
FY 2018 5y median -2.2× FY 2025
EV/Sales 1.0×
FY 2018 5y median 2.6× FY 2025
FCF Yield -83.5%
FY 2018 5y median -50.3% FY 2025
Profitability
Gross Margin 39.1%
FY 2018 5y median 22.2% FY 2025
Operating Margin -55.8%
FY 2018 5y median -127.2% FY 2025
Net Margin -68.3%
FY 2018 5y median -128.6% FY 2025
ROE -64.3%
FY 2018 5y median -66.2% FY 2025
ROIC -29.2%
FY 2018 5y median -46.1% FY 2025
ROA -30.9%
FY 2018 5y median -40.7% FY 2025
Growth (YoY)
Revenue 5.1%
FY 2018 FY 2025
Operating Income 41.2%
FY 2018 FY 2025
EPS (diluted) 85.5%
FY 2018 FY 2025
Free Cash Flow 59.8%
FY 2018 FY 2025
Financial Health
Current Ratio 6.7×
FY 2018 5y median 6.7× FY 2025
Quick Ratio 5.4×
FY 2018 5y median 5.4× FY 2025
Debt / Equity 0.8×
FY 2018 5y median 0.8× FY 2025
Net Debt / EBITDA -1.1×
FY 2018 5y median -0.4× FY 2025
Interest Coverage -4.8×
FY 2018 5y median -13.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
